Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Cancer Causes & Control
Erschienen in: Cancer Causes & Control 2/2019

17.01.2019 | Original Paper

Predictors of breast cancer mortality among white and black women in large United States cities: an ecologic study

verfasst von: Bijou R. Hunt, Abigail Silva, Derrick Lock, Marc Hurlbert

Erschienen in: Cancer Causes & Control | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We employed a city-level ecologic analysis to assess predictors of race-specific (black and white) breast cancer mortality rates.

Methods

We used data from the National Center for Health Statistics and the US Census Bureau to calculate 2010–2014 race-specific breast cancer mortality rates (BCMR) for 47 of the largest US cities. Data on potential city-level predictors (e.g., socioeconomic factors, health care resources) of race-specific BCMR were obtained from various publicly available datasets. We constructed race-specific multivariable negative binomial regression models to estimate rate ratios (RR) and 95% confidence intervals (CIs).

Results

Predictors of the white BCMR included white/black differences in education (RR 0.95; CI 0.91–0.99), number of religious congregations (RR 0.87; CI 0.77–0.97), and number of Medicare primary care physicians (RR 1.15; CI 1.04–1.28). Predictors of the black rate included white/black differences in household income (RR 1.03; CI 1.01–1.05), number of mammography facilities (RR 1.07; CI 1.03–1.12), and mammogram use (RR 0.93; CI 0.89–0.97).

Conclusions

Our ecologic analysis found that predictors of breast cancer mortality differ for the black and white rate. The results of this analysis could help inform interventions at the local level.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
DeSantis CE et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66(4):290–308CrossRefPubMed
2.
Hunt BR, Whitman S, Hurlbert MS (2014) Increasing Black:White disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol 38(2):118–123CrossRefPubMed
3.
Hunt BR, Hurlbert MS (2016) Black:White disparities in breast cancer mortality in the 50 largest cities in the United States, 2005–2014. Cancer Epidemiol 45:169–173CrossRefPubMed
4.
5.
Harding C et al (2015) Breast cancer screening, incidence, and mortality across US counties. JAMA Intern Med 175(9):1483–1489CrossRefPubMed
6.
Daly B, Olopade OI, A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin, 2015. 65(3): 221–238CrossRefPubMed
7.
Carey LA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502CrossRef
8.
O’Brien KM et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16(24):6100–6110CrossRefPubMedPubMedCentral
9.
Chlebowski RT et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439–448CrossRefPubMed
10.
Joslyn SA, West MM (2000) Racial differences in breast carcinoma survival. Cancer 88(1):114–123CrossRefPubMed
11.
Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56CrossRefPubMed
12.
Braithwaite D et al (2009) Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 124(5):1213–1219CrossRefPubMed
13.
Tammemagi CM et al (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772CrossRefPubMed
14.
Richards MA et al (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353(9159):1119–1126CrossRefPubMed
15.
Gorin SS et al (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166(20):2244–2252CrossRefPubMed
16.
Hershman D et al (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23(27):6639–6646CrossRefPubMed
17.
Wu X et al (2008) Survival difference between non-hispanic black and non-hispanic white women with localized breast cancer: the impact of guideline-concordant therapy. J Natl Med Assoc 100(5):490–498CrossRefPubMed
18.
Markossian TW, Hines RB, Bayakly R (2014) Geographic and racial disparities in breast cancer-related outcomes in Georgia. Health Serv Res 49(2):481–501CrossRefPubMed
19.
Akinyemiju T et al (2016) Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. Breast Cancer Res Treat 157(3):575–586CrossRefPubMedPubMedCentral
20.
White-Means S et al (2016) African American women: surviving breast cancer mortality against the highest odds. Int J Environ Res Public Health 13(1):ijerph13010006
21.
Rafalski E (2014) Building a community cancer registry: an effective call to clinical and policy intervention for reducing racial disparity in breast cancer mortality in Memphis, TN., in American Public Health Association (2014) New Orleans, LA
22.
Ansell D et al (2009) A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Causes Control 20(9):1681–1688CrossRefPubMed
23.
24.
Hunt B, Balachandran B (2015) Black:White disparities in lung cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol 39(6):908–916CrossRefPubMed
25.
Benjamins MR et al (2016) Racial disparities in heart disease mortality in the 50 largest U.S. cities. J Racial Ethn Health Dispar 4(5):967–975CrossRef
26.
27.
Benjamins MR et al (2016) Racial disparities in prostate cancer mortality in the 50 largest US cities. Cancer Epidemiol 44:125–131CrossRefPubMed
28.
Davidson PL et al (2005) Role of community risk factors and resources on breast carcinoma stage at diagnosis. Cancer 103(5):922–930CrossRefPubMed
29.
Blackman DJ, Masi CM (2006) Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 24(14):2170–2178CrossRefPubMed
30.
Flores YN et al (2013) Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis. BMC Public Health 13:1061CrossRefPubMedPubMedCentral
31.
Stoddard SW-M et al (2017) Breast cancer mortality disparities: providers’ perspective. Sciedu Press, Toronto
32.
Sposto R et al (2016) The effect of patient and contextual characteristics on racial/ethnic disparity in breast cancer mortality. Cancer Epidemiol Biomark Prev 25(7):1064–1072CrossRef
33.
34.
National Center for Health Statistics. Mortality – All County (micro-data) (2010–2014), as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program
35.
Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomark Prev 17(11):2913–2923CrossRef
36.
Shariff-Marco S et al (2015) Intersection of race/ethnicity and socioeconomic status in mortality after breast cancer. J Community Health 40(6):1287–1299CrossRefPubMedPubMedCentral
37.
Tehranifar P et al (2009) Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomark Prev 18(10):2701–2708
38.
39.
Levine RS et al (2010) Increased black-white disparities in mortality after the introduction of lifesaving innovations: a possible consequence of US federal laws. Am J Public Health 100(11):2176–2184CrossRefPubMedPubMedCentral
40.
Levine RS et al (2008) Black-white disparities in elderly breast cancer mortality before and after implementation of Medicare benefits for screening mammography. J Health Care Poor Underserved 19(1):103–134CrossRefPubMed
41.
Phelan JC, Link BG (2005) Controlling disease and creating disparities: a fundamental cause perspective. J Gerontol B Psychol Sci Soc Sci 60 Spec No 2:27–33CrossRefPubMed
42.
Rauscher GH et al., (2013) Mammogram image quality as a potential contributor to disparities in breast cancer stage at diagnosis: an observational study. BMC Cancer. 13: 208CrossRefPubMedPubMedCentral
43.
Rauscher GH et al (2012) Disparities in screening mammography services by race/ethnicity and health insurance. J Women’s Health 21(2):154–160CrossRef
44.
Rudolph L et al (2013) Health in all policies: a guide for state and local governments. Washington, DC, American Public Health Association
45.
Battaglia TA et al (2016) The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat 158(3):523–534CrossRefPubMedPubMedCentral
46.
Stanley S et al (2013) Reducing barriers to breast cancer care through Avon patient navigation programs. J Public Health Manag Pract 19(5):461–467CrossRefPubMed
47.
Ramachandran A et al (2015) Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: data from the patient navigation research program. Cancer 121(22):4016–4024CrossRefPubMedPubMedCentral
48.
Gabram SG et al (2008) Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer 113(3):602–607CrossRefPubMed
Metadaten
Titel
Predictors of breast cancer mortality among white and black women in large United States cities: an ecologic study
verfasst von
Bijou R. Hunt
Abigail Silva
Derrick Lock
Marc Hurlbert
Publikationsdatum
17.01.2019
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 2/2019
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1125-x

Weitere Artikel der Ausgabe 2/2019

Cancer Causes & Control 2/2019 Zur Ausgabe

Original Paper

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer

Original Paper

Physiologic serum 1,25 dihydroxyvitamin D is inversely associated with prostatic Ki67 staining in a diverse sample of radical prostatectomy patients

Original Paper

Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey

Brief report

Non-alcoholic fatty liver disease and colorectal cancer survival

Original Paper

Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women

Original paper

The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise